#USA #South San Francisco #Pharmacists #FDB #Medication Guidance

Revolutionizing Pharmacy Practice: Cutting Alerts by 70%

Introduction

In the quest for improved patient care and pharmacist efficiency, a groundbreaking research study reveals significant advancements in medication guidance. Clinical informatics pharmacists from FDB (First Databank, Inc.), a frontrunner in drug knowledge provision, presented their findings at the 2026 AMIA Amplify Informatics Conference. Their research indicates that a patient-specific approach to clinical decision support (CDS) can lead to a staggering 70% reduction in medication alerts within high-volume community pharmacy settings.

The Challenge

Community pharmacists currently face a barrage of alerts related to medication prescriptions. These alerts encompass numerous clinical domains, including drug-drug interactions, duplicate therapies, incorrect dosages, and contraindications. Each pharmacy visit can generate hundreds or even thousands of alerts, causing cognitive overload and burnout among pharmacists. In fact, before the implementation of FDB's new approach, pharmacists reported dealing with an average of 241.5 alerts for every 250 prescriptions.

The excessive alert notifications not only hinder pharmacists' daily operations but also increase the chances of overlooking critical safety signals, undermining the very purpose of these alerts.

The Innovative Approach

The FDB team proposed a risk-based, consolidated medication screening method. By mapping alerts to a singular clinical outcome— termed “Clinical Consequence” —the pharmacists were presented with a streamlined alert system that highlights the most pertinent risk for each patient, accompanied by actionable next steps. This approach replaced isolated severity-based alerts with a unified risk message, simplifying the decision-making process for pharmacists.

Key features of this new approach include:

• - Intelligent Alert Management: Suppression of repeated alerts based on prior overrides, ensuring pharmacists are not inundated with notifications about issues they've already addressed.
• - Expiration Logic: Automated expiration for alerts related to transient conditions (like ICD-10-CM codes), thus reducing unnecessary clutter.
• - Personalization: Alerts are tailored to patient-specific factors, ensuring that pharmacists receive notifications primarily relevant to their patient's situation.

Successful Results

Following the introduction of this consolidated approach, the data revealed a remarkable decrease in alert volume, dropping to fewer than 50 alerts per 250 prescriptions—a reduction of around 70%. Additionally, over 75% of pharmacists expressed acceptance of the recommended actions provided with the alerts, illustrating a marked improvement in job satisfaction and engagement.

Pharmacists reported dedicating more time to meaningful patient interactions rather than grappling with an overwhelming number of alerts. According to Dr. Usha Desiraju, Manager of Informatics and Clinical Content at FDB, “This research demonstrates that a consolidated approach can deftly align clinical decision support with the pharmacist’s workflow, ensuring that they are alerted only to the most critical information pertinent to each patient.”

Conclusion

As the healthcare landscape continually evolves, the role of community pharmacists is becoming increasingly critical. Implementing this innovative patient-specific medication guidance not only streamlines the work process for pharmacists but also enhances patient care experiences. FDB’s new solution, FDB Navigo™, exemplifies how integrating consolidated risk-based guidance into pharmacy workflows can create a more patient-centered practice, ready to meet the challenges of a modern healthcare environment.

For further information on FDB’s initiatives, visit FDB Health.